Comparing Remimazolam and Midazolam for Cataract Surgery
Official title: Comparison of Remimazolam vs. Midazolam for Sedation During Cataract Surgery
Run by University of California, Los Angeles · NCT05980117 · Data updated 2026-11-12
This study is testing if a new anesthesia called Remimazolam can help older patients have better thinking skills after cataract surgery compared to the standard anesthesia, Midazolam.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | March 10, 2025 |
| Main results expected | December 2025 |
| Study ends | January 2026 |
| Registry record updated | March 19, 2025 |
| Trial ID | NCT05980117 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 65 years old who are undergoing their first eye cataract surgery under local topical anesthesia.
✕Probably not a fit
Patients who cannot consent, have significant cognitive impairments, or do not wish to receive benzodiazepines during surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate postoperative cognitive changes in elderly patients undergoing cataract surgery by comparing the effects of two benzodiazepines: Midazolam and Remimazolam. Participants will be randomly assigned to receive either medication during surgery, and cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA) before surgery, at discharge, and the following day. The study seeks to determine if Remimazolam, with its shorter half-life, results in fewer cognitive changes compared to Midazolam. Additionally, patient satisfaction regarding anesthesia will be measured at discharge.
Why it matters
Potential benefit: If successful, this study could lead to improved cognitive outcomes for elderly patients undergoing cataract surgery.
How similar studies have gone: Other studies have explored the effects of different anesthetics on cognitive outcomes, but this specific comparison of Remimazolam and Midazolam in cataract surgery is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult patients age \> 65 years undergoing first eye cataract surgery under local topical anesthesia at the University of California, Los Angeles (UCLA). 2. Both male and female patients 3. American Society of Anesthesiologists Class 2, 3, and 4. Exclusion Criteria: 1. Patients who are unable to consent for the study 2. Patients who are unable to cooperate with the cognitive assessment such as patients with significant visual, auditory, language or other impairment. 3. Patients who are unable to understand simple English commands. 4. Patients who do not wish to have benzodiazepine medication during surgery 5. Patients with a history of severe hypersensitivity reaction to dextran 40 or products containing dextran 40. 6. Patients with chronic pain on opiates. 7. Patients with a history of drug, alcohol abuse/dependence. 8. Patients with BMI \> 40. 9. Patients with obstructive sleep apnea (moderate to severe).
Where it's running
-
Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Zhuang Fang, MD — University of California, Los Angeles
- Study coordinator: Zhuang T Fang, MD
- Email: ZFang@mednet.ucla.edu
- Phone: 310-267-8946
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Cardiovascular and Cognitive Health Initiative
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
-
Feasibility of using a head-mounted spatial display during intraocular surgery
This study tests whether Apple Vision Pro can help surgeons visualize information during cataract and other intraocular surgeries.
-
Synbiotic blend of LA-5 and agave inulin for mild cognitive impairment
This pilot crossover study tests whether a synbiotic containing Lactobacillus acidophilus LA-5 and agave inulin can help adults aged 60–75 with mild cognitive impairment.
-
Lacrifill to Help Prevent Post-Curgery Dry Eye After Cataract Surgery
This study tests Lacrifill to see if it helps prevent dry eye symptoms after unilateral cataract surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.